Recurrent Neuroblastoma Completed Phase 3 Trials for Isotretinoin (DB00982)

Also known as: Neuroblastoma Recurrent

IndicationStatusPhase
DBCOND0028756 (Recurrent Neuroblastoma)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00567567Comparing Two Different Myeloablation Therapies in Treating Young Patients Who Are Undergoing a Stem Cell Transplant for High-Risk NeuroblastomaTreatment
NCT00026312Isotretinoin With or Without Dinutuximab, Aldesleukin, and Sargramostim Following Stem Cell Transplant in Treating Patients With NeuroblastomaTreatment